Benzinga’s Top Upgrades (VQ, JOYG, TIBX, GSK, SYT)
Venoco Inc (NYSE: VQ) was upgraded by Wells Fargo from “market perform” to “outperform.” VQ’s shares closed at $13.83 yesterday. Venoco is likely to earn 87.98% this year.
Goldman Sachs upgraded Joy Global Inc (NASDAQ: JOYG) from “neutral” to “buy.” JOYG’s shares closed at $48.44 yesterday. Joy Global’s earnings have grown 57.18% over the past 5 years.
Goldman Sachs upgraded Tibco Software Inc (NASDAQ: TIBX) from “sell” to “neutral.” TIBX closed at $11.18 yesterday. Tibco Software’s quarterly earnings jumped 87.89%.
Analysts at Jefferies & Co upgraded GlaxoSmithKline plc (NYSE: GSK) from “hold” to “buy.” GSK’s shares closed at $33.66 yesterday. GlaxoSmithKline’s trailing-twelve-month gross margin is 73.94%,
Syngenta (NYSE: SYT) has been upgraded to “outperform” from “neutral” by Credit Suisse. SYT’s shares closed at $43.91 yesterday. Syngenta’s quarterly earnings moved up 89.52%.
